While the medications themselves remain undetectable in routine laboratory work, their therapeutic effectsincluding improved hemoglobin A1c, fasting glucose, and lipid profilesare clearly measurable
Combining two incretin-based therapies creates dangerous overlapping receptor activation
A clinical study involving 564 adults (BMI 30-40 kg/m2, without T2DM) found that compared with orlistat (3120 mg, weight loss of 4.1 kg), LIR (subcutaneous administration of 1.2 mg/d, 1.8 mg/d, 2.4 mg/d or 3 mg/d) had an average weight loss of 4.8-7.2 kg, the two-year extended experiment of which also showed similar results (88, 89)
Diabetes Obes Metab (2021) 23:11624
How many units of semaglutide is 0.25mg from a 5mg vial
The evolving therapeutic landscape demands we weigh metformins benefits against newer agents that offer more than glucose control alone